Milestone Shows Stratus’ Commitment to Care for People with Seizures and Epilepsy
DALLAS, TX (July 19, 2023) – Stratus, the nation’s leading provider of neurodiagnostic solutions and services, today announced it has officially provided services to more than 100,000 patients in the United States. This milestone in patient care is a testament to Stratus’ ongoing commitment to improve access to care and help patients receive high-quality diagnostic services.
Stratus was one of the pioneers in offering in-home neurodiagnostic services to physicians and their patients. Additionally, the company has continually been at the forefront of advancing access to and the quality of diagnostic data. This data is a critical component of a physician’s decision on diagnosing and managing a patient’s condition. One of these services, a diagnostic long-term video electroencephalogram (VEEG), in many cases does not require a hospital stay and sending a person to the hospital can unnecessarily increase costs and, in some cases, reduce the likelihood of capturing stress induced seizures or seizure-like symptoms. The neurology community has increasingly embraced this approach, which is backed by clinical evidence, and has contributed to Stratus’ growth. In addition to long-term video EEG, Stratus offers inpatient EEG monitoring services and ambulatory electrocardiograms as well.
“We’re grateful to the physicians, patients, parents, and caregivers who have trusted us to provide their testing and enabled the company to reach this momentous milestone,” said Charlie Alvarez, CEO of Stratus. “Stratus’ vision is to provide best-in-class service and we are committed to continuing to lead the industry forward in neurodiagnostics. We look forward to the opportunity to continue to serve physicians and their patients.”
Stratus is the nation’s leading provider of EEG solutions and has served more than 100,000 patients across the U.S. The company offers technology, services, and proprietary software solutions to help neurologists diagnose their patients with epilepsy and other seizure-like disorders accurately and quickly. Stratus also provides electrocardiograms to support the diagnostic testing needs of the neurology community. Additionally, the company’s R&D division holds the world’s largest database of de-identified EEG recordings and is applying machine learning to improve the overall quality and efficiency of EEG testing. To learn more, visit www.stratusneuro.com.